Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 13, 2021

SELL
$42.51 - $63.78 $1.1 Million - $1.65 Million
-25,809 Closed
0 $0
Q4 2020

Feb 10, 2021

SELL
$45.3 - $60.27 $865,683 - $1.15 Million
-19,110 Reduced 42.54%
25,809 $1.46 Million
Q3 2020

Nov 12, 2020

BUY
$47.45 - $62.95 $307,001 - $407,286
6,470 Added 16.83%
44,919 $2.13 Million
Q2 2020

Aug 13, 2020

SELL
$46.85 - $61.05 $1.75 Million - $2.28 Million
-37,284 Reduced 49.23%
38,449 $2.27 Million
Q1 2020

May 14, 2020

BUY
$41.6 - $63.4 $3.15 Million - $4.8 Million
75,733 New
75,733 $3.58 Million
Q3 2019

Nov 12, 2019

SELL
$59.06 - $72.15 $12.2 Million - $15 Million
-207,238 Closed
0 $0
Q2 2019

Jul 30, 2019

SELL
$62.09 - $86.14 $20,303 - $28,167
-327 Reduced 0.16%
207,238 $13.3 Million
Q4 2018

Feb 12, 2019

BUY
$43.37 - $59.54 $285,721 - $392,249
6,588 Added 3.28%
207,565 $11.2 Million
Q3 2018

Nov 13, 2018

SELL
$42.88 - $53.7 $318,512 - $398,883
-7,428 Reduced 3.56%
200,977 $10.4 Million
Q2 2018

Aug 01, 2018

SELL
$40.53 - $50.7 $162,930 - $203,814
-4,020 Reduced 1.89%
208,405 $8.68 Million
Q1 2018

May 14, 2018

SELL
$44.08 - $55.05 $48,443 - $60,499
-1,099 Reduced 0.51%
212,425 $9.36 Million
Q4 2017

Feb 13, 2018

BUY
$50.3 - $64.39 $339,022 - $433,988
6,740 Added 3.26%
213,524 $10.7 Million
Q3 2017

Nov 13, 2017

BUY
$45.56 - $59.57 $297,324 - $388,753
6,526 Added 3.26%
206,784 $10.5 Million
Q2 2017

Aug 07, 2017

BUY
N/A
200,258
200,258 $10.2 Million

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.35B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Aviva PLC Portfolio

Follow Aviva PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aviva PLC, based on Form 13F filings with the SEC.

News

Stay updated on Aviva PLC with notifications on news.